A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer

This study has been completed.
Sponsor:
Collaborators:
Bristol-Myers Squibb
Beth Israel Deaconess Medical Center
Lowell General Hospital
Massachusetts General Hospital
Oregon Health and Science University
Wentworth-Douglass Hospital
Information provided by:
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00134706
First received: August 24, 2005
Last updated: December 7, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)